Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Recently granted patents

New US pharmaceutical patent grants from the past 12 months — competitive surveillance for BD and IP teams.

Patents
890

Quick answer

890 pharmaceutical patents in our USPTO index were granted within the past year. Browse by grant date with links to applicant company portfolios and related drug profiles.

  1. WO 2026006398

    RÉDUCTASES D'IMINE MODIFIÉES ET LEURS PROCÉDÉS D'UTILISATION

    AMGEN INC [US] · Granted Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2026006232

    COMPOSITION EFFERVESCENTE ORALE

    BAYER HEALTHCARE LLC [US] · Granted Fri Jan 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 20260001878

    SUBSTITUTED PYRROLOPYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF TLR9

    BRISTOL MYERS SQUIBB CO [US] · Granted Thu Jan 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. EP 4670742

    ANTI-CD79B-ANTIKÖRPER-WIRKSTOFFKONJUGATE

    ABBVIE INC [US] · Granted Wed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. WO 2025265110

    COMPOSITIONS PHARMACEUTIQUES ORALES RENFERMANT UN COMPOSÉ DE NAPHTYRIDINE

    AMGEN INC [US] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2025262130

    CONJUGUÉ ANTICORPS-MÉDICAMENT

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. WO 2025262150

    MOLÉCULES DE RECRUTEMENT D'ANTICORPS

    ABLYNX NV [BE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2025261951

    POLYTHÉRAPIE AVEC UN ANTICORPS ANTI-CA19-9 ET DU FOLFIRINOX DANS LE TRAITEMENT DU CANCER

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2025262460

    COMPOSITIONS LIPIDIQUES POUR L'ADMINISTRATION D'ACIDES NUCLÉIQUES

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2025264662

    COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'UN MÉLANOME

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. WO 2025260285

    CONJUGUÉ ANTICORPS-MÉDICAMENT

    DUALITY BIOLOGICS SUZHOU CO LTD [CN] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2025261607

    PARTICULES, COMPOSITIONS ET PROCÉDÉS

    BIONTECH SE [DE] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2025265012

    COMPOSITIONS COMPRENANT DES ANTICORPS ANTI-PCSK9

    AMGEN INC [US] · Granted Fri Dec 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Dec 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 2025388678

    Methods, Combinations, and Uses for the Treatment of Muscle Invasive Bladder Cancer

    ASTRAZENECA AB [SE] · Granted Thu Dec 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 2025382344

    Soluble GLP1/GIP/NPY2 Receptor Triple Agonists

    BOEHRINGER INGELHEIM INT GMH [DE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. WO 2025259831

    FORMES CRISTALLINES D'UN ANTAGONISTE DE LPA1

    BRISTOL MYERS SQUIBB CO [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. WO 2025260042

    CONSTRUCTIONS D'ARNI ET PROCÉDÉS D'INHIBITION DE L'EXPRESSION DE CNR1

    AMGEN INC [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. WO 2025257199

    THÉRAPIES POUR LE TRAITEMENT DE PLAIES

    ASTRAZENECA AB [SE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. WO 2025257278

    SÉQUENCES IMMUNOGÈNES

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2025256977

    NOUVELLES ENZYMES DE CLIVAGE IGM ET IGG

    BAYER AG [DE] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. WO 2025259515

    POLYTHÉRAPIE

    AMGEN INC [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. WO 2025259749

    FRAGMENTS VARIABLES À CHAÎNE UNIQUE STABLES

    AMGEN INC [US] · Granted Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. WO 2025252204

    DISPERSIONS SOLIDES AMORPHES D'UN INHIBITEUR DE BRAF

    BEIGENE SUZHOU CO LTD [CN] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. AU 2025242171

    A Medicament and Method of Treatment of Central Nervous System and/or Neuropsychiatric Disorders

    BEIGENE SWITZERLAND GMBH [CH] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. WO 2025252715

    AGONISTE DOUBLE DU RÉCEPTEUR DU GLP-1 ET DU GLUCAGON POUR LE TRAITEMENT DE LA MASH ET DE LA CIRRHOSE

    BOEHRINGER INGELHEIM INT [DE] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. WO 2025252599

    COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3

    ANGELINI PHARMA S P A [IT] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. WO 2025252600

    COMPOSÉS ACTIVATEURS DE CANAUX POTASSIQUES KV7.2/KV7.3

    ANGELINI PHARMA S P A [IT] · Granted Thu Dec 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Dec 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. WO 2025250831

    CONJUGUÉS ANTICORPS-MÉDICAMENT IMMUNOSTIMULANTS À BASE D'AGONISTE DE STING

    ASTELLAS PHARMA INC [JP] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. WO 2025250569

    TRAITEMENTS DU CANCER UTILISANT DES INHIBITEURS DE PRMT5 MTA-COOPÉRATIFS ET DES INHIBITEURS DE MAT2A

    AMGEN INC [US] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. WO 2025247801

    DÉTERMINATION D'UN DOSAGE D'UN ANTAGONISTE DU RÉCEPTEUR MINÉRALOCORTICOÏDE NON STÉROÏDIEN

    BAYER AG [DE] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. WO 2025247981

    DOSAGE PHARMACEUTIQUE DÉRIVÉ DE FUROINDAZOLE

    BAYER AG [DE] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. WO 2025248117

    DÉRIVÉS DE 6-AMINOPURINE UTILES EN TANT QU'INHIBITEURS DE POLQ

    ASTRAZENECA AB [SE] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. AU 2024276234

    METHODS OF TREATMENT USING ANTI-C-MET ANTIBODY DRUG CONJUGATES

    ABBVIE MFG MANAGEMENT UNLIMITED COMPANY [IE] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. WO 2025248119

    DÉRIVÉS DE 6-(CYCLO)ALCOXYPURINE UTILES EN TANT QU'INHIBITEURS DE POLQ

    ASTRAZENECA AB [SE] · Granted Thu Dec 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. MX 2025012909

    METHOD FOR INDUCING AN IMMUNE RESPONSE

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Sun Nov 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. WO 2025242585

    FORMES CRISTALLINES DE SELS D'ÉLINZANÉTANT ET COMPOSITIONS CONTENANT DES SELS D'ÉLINZANÉTANT

    BAYER CONSUMER CARE AG [CH] · Granted Thu Nov 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. WO 2025242689

    MÉTHODES DE TRAITEMENT D'UNE MALADIE RÉNALE MÉDIÉE PAR APOL1

    ASTRAZENECA AB [SE] · Granted Thu Nov 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. WO 2025242584

    FORMULATION DE CAPSULE DE GÉLATINE MOLLE STABLE POUR ÉLINZANÉTANT

    BAYER CONSUMER CARE AG [CH] · Granted Thu Nov 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. WO 2025242583

    NOUVELLE FORMULATION COMPRENANT DE L'ÉLINZANÉTANT DANS UNE DISPERSION SOLIDE

    BAYER CONSUMER CARE AG [CH] · Granted Thu Nov 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. WO 2025238219

    VIRUS MODIFIÉ DE LA VACCINE ANKARA (MVA) CODANT POUR DES NANOPARTICULES PROTÉIQUES PRÉSENTANT DES ANTIGÈNES

    BAVARIAN NORDIC AS [DK] · Granted Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. WO 2025238220

    ACIDES NUCLÉIQUES POUR LA VACCINATION CODANT POUR DES NANOPARTICULES DE PROTÉINE DE PRÉSENTATION DES ANTIGÈNES

    BAVARIAN NORDIC AS [DK] · Granted Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. WO 2025238159

    POLYTHÉRAPIE COMPRENANT DE L'AZD0780 ET DE L'ÉZÉTIMIBE

    ASTRAZENECA AB [SE] · Granted Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. WO 2025238218

    VECTEURS VIRAUX CODANT POUR DES NANOPARTICULES DE PROTÉINE D'AFFICHAGE D'ANTIGÈNE

    BAVARIAN NORDIC AS [DK] · Granted Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. WO 2025238221

    VECTEURS VIRAUX CODANT POUR DES NANOPARTICULES DE PROTÉINE À PRÉSENTATION D'ANTIGÈNES MULTIPLES

    BAVARIAN NORDIC AS [DK] · Granted Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. WO 2025237912

    INHIBITEURS DE KEAP1 DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE LA BRONCHECTASIE

    ASTRAZENECA AB [SE] · Granted Thu Nov 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. WO 2025232885

    PROCÉDÉ DE PRÉPARATION D'UN AGENT DE DÉGRADATION DE LA TYROSINE KINASE DE BRUTON

    BEIGENE SUZHOU CO LTD [CN] · Granted Thu Nov 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. WO 2025233501

    CONJUGUÉS COMPRENANT UN INHIBITEUR DE TOPOISOMÉRASE I

    ASTRAZENECA AB [SE] · Granted Thu Nov 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. WO 2025233516

    MÉTHODE D'AUGMENTATION DU TEMPS JUSQU'À LA DEUXIÈME PROGRESSION ET DU TEMPS JUSQU'À LA PREMIÈRE CHIMIOTHÉRAPIE SUIVANTE

    ASTRAZENECA AB [SE] · Granted Thu Nov 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How recent are these patent grants?

This hub lists published patents with a grant date within the last 365 days, ordered newest first.

Which patent classes are included?

We index USPTO PatentsView records with pharmaceutical CPC classifications A61K and A61P linked to tracked assignee companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.